Quad-Cities Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Quad-Cities Investment Group's BMY Position: Q4 2023 in Review
Quad-Cities Investment Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,573 shares — an estimated $207K sold.
Quad-Cities Investment Group first reported a position in BMY in Q1 2018 and held it in 23 quarters. The position peaked at $412K in Q1 2018. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Quad-Cities Investment Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Quad-Cities Investment Group sold 3,573 Bristol-Myers Squibb shares in Q4 2023, an estimated $207K.
- Quad-Cities Investment Group first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 23 quarters.
- Quad-Cities Investment Group's Bristol-Myers Squibb position peaked at $412K in Q1 2018.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Quad-Cities Investment Group's 13F filing for Q4 2023, filed 10 Jan 2024.